Lexeo Therapeutics (LXEO) Operating Leases: 2022-2023
- Lexeo Therapeutics' Operating Leases was N/A to $8.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $8.1 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2022, which is N/A change from last year.
- According to the latest figures from Q3 2023, Lexeo Therapeutics' Operating Leases is $8.1 million, which was down 9.86% from $9.0 million recorded in Q4 2022.
- Lexeo Therapeutics' 5-year Operating Leases high stood at $9.0 million for Q4 2022, and its period low was $8.1 million during Q3 2023.
- Its 2-year average for Operating Leases is $8.6 million, with a median of $8.6 million in 2022.
